PURPOSE: Bilateral cavernous nerve injury results in up-regulation of ROCK signaling in the penis. This is linked to erectile dysfunction in an animal model of post-prostatectomy erectile dysfunction. We evaluated whether daily treatment with the ROCK inhibitor Y-27632 (Tocris Bioscience, Ellisville, Missouri) would prevent erectile dysfunction in a rat model of bilateral cavernous nerve injury. MATERIALS AND METHODS: Sprague-Dawley® rats underwent surgery to create sham (14) or bilateral (27) cavernous nerve injury. In the injury group 13 rats received treatment with Y-27632 (5 mg/kg twice daily) and 14 received vehicle. At 14 days after injury, rats underwent cavernous nerve stimulation to determine erectile function. Penes were assessed for neuronal and nitric oxide synthase membrane-endothelial nitric oxide synthase. ROCK2 was assessed by Western blot. Cyclic guanosine monophosphate was determined by enzyme-linked immunosorbent assay. Cavernous homogenates were tested for ROCK and protein kinase G enzymatic activity. Penile apoptosis was evaluated using the Apostain technique (Alexis, San Diego, California). Data were analyzed on ROCK using ANOVA and the t test. RESULTS: While erectile function was decreased in rats with bilateral cavernous nerve injury, daily administration of Y-27632 improved erectile responses. Injury decreased neuronal and nitric oxide synthase membrane-endothelial nitric oxide synthase but ROCK2 was significantly increased. Y-27632 treatment restored neuronal nitric oxide synthase, nitric oxide synthase membrane-endothelial nitric oxide synthase and cyclic guanosine monophosphate levels, and protein kinase G activity. Treatment significantly decreased ROCK2 protein and ROCK activity. There were significantly fewer apoptotic cells after treatment than in injured controls. CONCLUSIONS: These results provide evidence for up-regulation of the RhoA/ROCK signaling pathway with detrimental effects on erectile function after bilateral cavernous nerve injury. ROCK inhibition improved erectile dysfunction associated with bilateral cavernous nerve injury by preserving penile nitric oxide bioavailability and decreasing penile apoptosis.
PURPOSE: Bilateral cavernous nerve injury results in up-regulation of ROCK signaling in the penis. This is linked to erectile dysfunction in an animal model of post-prostatectomy erectile dysfunction. We evaluated whether daily treatment with the ROCK inhibitor Y-27632 (Tocris Bioscience, Ellisville, Missouri) would prevent erectile dysfunction in a rat model of bilateral cavernous nerve injury. MATERIALS AND METHODS: Sprague-Dawley® rats underwent surgery to create sham (14) or bilateral (27) cavernous nerve injury. In the injury group 13 rats received treatment with Y-27632 (5 mg/kg twice daily) and 14 received vehicle. At 14 days after injury, rats underwent cavernous nerve stimulation to determine erectile function. Penes were assessed for neuronal and nitric oxide synthase membrane-endothelial nitric oxide synthase. ROCK2 was assessed by Western blot. Cyclic guanosine monophosphate was determined by enzyme-linked immunosorbent assay. Cavernous homogenates were tested for ROCK and protein kinase G enzymatic activity. Penile apoptosis was evaluated using the Apostain technique (Alexis, San Diego, California). Data were analyzed on ROCK using ANOVA and the t test. RESULTS: While erectile function was decreased in rats with bilateral cavernous nerve injury, daily administration of Y-27632 improved erectile responses. Injury decreased neuronal and nitric oxide synthase membrane-endothelial nitric oxide synthase but ROCK2 was significantly increased. Y-27632 treatment restored neuronal nitric oxide synthase, nitric oxide synthase membrane-endothelial nitric oxide synthase and cyclic guanosine monophosphate levels, and protein kinase G activity. Treatment significantly decreased ROCK2 protein and ROCK activity. There were significantly fewer apoptotic cells after treatment than in injured controls. CONCLUSIONS: These results provide evidence for up-regulation of the RhoA/ROCK signaling pathway with detrimental effects on erectile function after bilateral cavernous nerve injury. ROCK inhibition improved erectile dysfunction associated with bilateral cavernous nerve injury by preserving penile nitric oxide bioavailability and decreasing penile apoptosis.
Authors: Christian Gratzke; Travis D Strong; Milena A Gebska; Hunter C Champion; Christian G Stief; Arthur L Burnett; Trinity J Bivalacqua Journal: J Urol Date: 2010-09-18 Impact factor: 7.450
Authors: O Kutlu; A E Ross; E M Schaeffer; C Gratzke; C G Stief; T D Strong; A L Burnett; P Hedlund; T J Bivalacqua Journal: Int J Impot Res Date: 2011-10-13 Impact factor: 2.896
Authors: John P Mulhall; Alexander Müller; John F Donohue; Michael Mullerad; Keith Kobylarz; Darius A Paduch; Raanan Tal; Philip S Li; Leona Cohen-Gould; Peter T Scardino Journal: J Sex Med Date: 2008-03-04 Impact factor: 3.802
Authors: Jeffrey J Lysiak; Sang-Kuk Yang; Adam P Klausner; Hwancheol Son; Jeremy B Tuttle; William D Steers Journal: J Urol Date: 2007-12-20 Impact factor: 7.450
Authors: Hotaka Matsui; Biljana Musicki; Nikolai A Sopko; Xiaopu Liu; Paula J Hurley; Arthur L Burnett; Trinity J Bivalacqua; Johanna L Hannan Journal: Urology Date: 2016-09-14 Impact factor: 2.649
Authors: Johanna L Hannan; Maarten Albersen; Bernard L Stopak; Xiaopu Liu; Arthur L Burnett; Ahmet Hoke; Trinity J Bivalacqua Journal: J Neurosci Res Date: 2015-01-19 Impact factor: 4.164
Authors: Johanna L Hannan; Omer Kutlu; Bernard L Stopak; Xiaopu Liu; Fabio Castiglione; Petter Hedlund; Arthur L Burnett; Trinity J Bivalacqua Journal: J Sex Med Date: 2014-03-18 Impact factor: 3.802
Authors: Carol A Podlasek; John Mulhall; Kelvin Davies; Christopher J Wingard; Johanna L Hannan; Trinity J Bivalacqua; Biljana Musicki; Mohit Khera; Nestor F González-Cadavid; Arthur L Burnett Journal: J Sex Med Date: 2016-08 Impact factor: 3.802
Authors: Hotaka Matsui; Nikolai A Sopko; Johanna L Hannan; Allison A Reinhardt; Max Kates; Takahiro Yoshida; Xiaopu Liu; Fabio Castiglione; Petter Hedlund; Emmanuel Weyne; Maarten Albersen; Trinity J Bivalacqua Journal: J Sex Med Date: 2017-02 Impact factor: 3.802
Authors: Nikolai A Sopko; Hotaka Matsui; Johanna L Hannan; Dan Berkowitz; Hunter C Champion; Lewis L Hsu; Biljana Musicki; Arthur L Burnett; Trinity J Bivalacqua Journal: J Sex Med Date: 2015-09-07 Impact factor: 3.802